Skip to main content
Caplight Logo









LifeShield Medical

LifeShield Medical

Private
AachenHealthcare & Life Scienceshttps://lifeshield-medical.com/

Last Round

Series B

Oct 8, 2023

Total Funding Raised

$29.47M

Company Overview

LifeShield Medical is a healthcare company that develops and manufactures advanced cardiopulmonary support systems, including ECMO and pVAD technologies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

ECMOextracorporeal membrane oxygenationECCO2Rextracorporeal carbon dioxide removalcardiopulmonary supportlife support systemsmedtechheart-lung machineinterventional cardiac supportcritical care equipmentmedical device manufacturerpVADoriginal design manufacturingODMISO 13485

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LifeShield Medical Comparables

Compare LifeShield Medical with similar companies based on industry and business-model similarity.

LifeShield Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chinabridge (Shenzhen) Medical Technology Co., Ltd.
86%
Jiangsu STMed Technology Co., Ltd.
84%
MicroPort Scientific Corporation
84%

LifeShield Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 8, 2023
Series AJan 21, 2022

LifeShield Medical Investors

Notable investors and investment history

LifeShield Medical investors
InvestorRounds
Lingang Blue Bay CapitalSeries B
Sherpa Healthcare PartnersSeries B
Proxima Ventures Ltd.Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 8, 2023

    $14M round led by Sherpa Healthcare Partners.

LifeShield Medical Filings

Explore SEC and related filing metadata, where available.

LifeShield Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LifeShield Medical's valuation, stock price, and market status.

Is LifeShield Medical a public or private company?

LifeShield Medical is a private company.

What is the current stock price of LifeShield Medical?

LifeShield Medical is a private company with no public stock price. Caplight tracks LifeShield Medical's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is LifeShield Medical worth (valuation)?

Valuation information for LifeShield Medical is not publicly available.

Can I buy LifeShield Medical stock?

LifeShield Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LifeShield Medical's last funding round?

LifeShield Medical's most recent funding round was Series B on October 8, 2023.

Who are the main investors in LifeShield Medical?

Key investors in LifeShield Medical include Sherpa Healthcare Partners.

Will LifeShield Medical IPO soon?

No public IPO plans have been announced for LifeShield Medical.

How can I track LifeShield Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LifeShield Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAachen
Year Founded2021
Last FundingOct 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?